The work led by UB bioengineers Ruogang Zhao and Yun Wu may help discover new drugs to treat pulmonary fibrosis, a severe lung disease that has no cure.
Household members of anyone who recently tested positive for COVID-19 are being recruited for Regeneron’s national clinical trial of the investigational antibody cocktail REGN-COV2.
The partnership is working to advance affordable, new antivirals and vaccines for neglected infectious diseases such as the dengue, Zika and Chikungunya viruses.